Skip to main content
SpringerLink
Log in

Oesophageal Cancer

  • Chapter
Pocket Manual of General Thoracic Surgery

  • 2283 Accesses

Abstract

This chapter summarizes the work-up, staging and management of oesophageal cancer. The various controversies are outlined with a critical appraisal of the literature. Barrett’s oesophagus is also reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ronkainen J et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825–31.

    Article  PubMed  Google Scholar 

  2. Hirota WK et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology. 1999;116(2):277–85.

    Article  CAS  PubMed  Google Scholar 

  3. Sharma P et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–9.

    Article  PubMed  Google Scholar 

  4. Desai TK et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut. 2012;61(7):970–6.

    Article  PubMed  Google Scholar 

  5. Max Almond L, Barr H. Management controversies in Barrett’s oesophagus. J Gastroenterol. 2014;49(2):195–205.

    Google Scholar 

  6. Ortiz A et al. Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg. 1996;83(2):274–8.

    Article  CAS  PubMed  Google Scholar 

  7. Shaheen NJ et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360(22):2277–88.

    Article  CAS  PubMed  Google Scholar 

  8. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.

    Article  PubMed  Google Scholar 

  9. Pech O et al. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann Surg. 2011;254(1):67–72.

    Article  PubMed  Google Scholar 

  10. Zehetner J et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. J Thorac Cardiovasc Surg. 2011;141(1):39–47.

    Article  PubMed  Google Scholar 

  11. Nigro JJ et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg. 1999;117(1):16–23. discussion 23-5.

    Article  CAS  PubMed  Google Scholar 

  12. Stein HJ et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242(4):566–73. discussion 573-5.

    PubMed Central  PubMed  Google Scholar 

  13. Westerterp M et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446(5):497–504.

    Article  PubMed  Google Scholar 

  14. Tajima Y et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88(6):1285–93.

    Article  CAS  PubMed  Google Scholar 

  15. Ancona E et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol. 2008;15(11):3278–88.

    Article  PubMed  Google Scholar 

  16. Lee L et al. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg. 2013;217(2):191–9.

    Article  PubMed  Google Scholar 

  17. Rice TW et al. T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg. 2007;133(2):317–24.

    Article  PubMed  Google Scholar 

  18. Macdonald JS et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725–30.

    Article  CAS  PubMed  Google Scholar 

  19. van Hagen P et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.

    Article  PubMed  Google Scholar 

  20. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology – Esophageal and Esophagogastric Junction Cancers. 2013. 2.2013.

    Google Scholar 

  21. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007;11(11):1384–93. discussion 1393-4.

    Article  PubMed  Google Scholar 

  22. Peyre CG et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248(4):549–56.

    PubMed  Google Scholar 

  23. Lee PC et al. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma. J Thorac Cardiovasc Surg. 2011;141(5):1196–206.

    Article  PubMed  Google Scholar 

  24. Taylor MD et al. Induction chemoradiotherapy and surgery for esophageal cancer: survival benefit with downstaging. Ann Thorac Surg. 2013;96(1):225–30. discussion 230-1.

    Article  PubMed  Google Scholar 

  25. Sjoquist KM et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681–92.

    Article  PubMed  Google Scholar 

  26. Manner H et al. Early Barrett's carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008;103(10):2589–97.

    Article  PubMed  Google Scholar 

  27. Bedenne L et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(10):1160–8.

    Article  CAS  PubMed  Google Scholar 

  28. Stahl M et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23(10):2310–7.

    Article  PubMed  Google Scholar 

  29. Mariette C et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014;32(23):2416–22.

    Article  CAS  PubMed  Google Scholar 

  30. Walsh TN et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335(7):462–7.

    Article  CAS  PubMed  Google Scholar 

  31. Medical Research Council Oesophageal Cancer Working G. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359(9319):1727–33.

    Article  Google Scholar 

  32. Ychou M et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715–21.

    Article  CAS  PubMed  Google Scholar 

  33. Cunningham D et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.

    Article  CAS  PubMed  Google Scholar 

  34. Ferri LE et al. Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial. Ann Oncol. 2012;23(6):1512–7.

    Article  CAS  PubMed  Google Scholar 

  35. Rice TW et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg. 2003;126(5):1590–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, McGill University Health Center, Montreal, QC, Canada

    Amin Madani M.D.

  2. Division of Surgery, McGill University Health Center, Montreal, QC, Canada

    Sara Najmeh M.D. & Abdullah Aloraini

Authors
  1. Amin Madani M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara Najmeh M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abdullah Aloraini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sara Najmeh M.D. .

Editor information

Editors and Affiliations

  1. McGill University, Montreal, Québec, Canada

    Amin Madani

  2. McGill University, Montreal, Québec, Canada

    Lorenzo Ferri

  3. The Ottawa Hospital – General Campus, University of Ottawa, Ottawa, Ontario, Canada

    Andrew Seely

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Madani, A., Najmeh, S., Aloraini, A. (2015). Oesophageal Cancer. In: Madani, A., Ferri, L., Seely, A. (eds) Pocket Manual of General Thoracic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-17497-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17497-6_9

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17496-9

  • Online ISBN: 978-3-319-17497-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation